Study of NIVOLUMAB/IPILIMUMAB Maintenance in Unresectable Locally Advanced or Metastatic Urothelial Cancer
Clinical trial NCT05219435 · COMPLETED
Trial details
- NCT number
- NCT05219435
- Sponsor
- Spanish Oncology Genito-Urinary Group
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-06
- Primary completion
- 2025-07-10
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.